Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Takuya Watanabe,Yuji Suzuki,Hidekatsu Kuroda,Hayato Hiraki,Akiko Suzuki, Akio Tamura, Yoshiro Ieko,Satoshi S Nishizuka,Takayuki Matsumoto

Oncology（2023）

引用 0|浏览2

暂无评分

摘要

The baseline plasma cfDNA concentration can be used as a prognostic biomarker in patients with advanced HCC. cfDNA kinetics may also predict the tumor response to therapy and disease progression.

查看译文

关键词

hepatocellular carcinoma,dna,biomarker,cell-free

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要